tiprankstipranks
Trending News
More News >
Axon Enterprise (AXON)
NASDAQ:AXON

Axon Enterprise (AXON) AI Stock Analysis

Compare
3,971 Followers

Top Page

AXON

Axon Enterprise

(NASDAQ:AXON)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 4o)
Rating:58Neutral
Price Target:
$555.00
▼(-9.46% Downside)
Axon's overall score is driven by strong earnings call results and growth potential, but is weighed down by technical analysis indicating bearish momentum and high valuation concerns. Financial performance shows growth but highlights risks in profitability and cash flow management.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective business strategies, supporting long-term financial health.
Software and Services Expansion
Growth in software and services enhances recurring revenue streams, improving financial stability and customer retention.
International Market Expansion
Successful international expansion diversifies revenue sources and reduces reliance on domestic markets, enhancing growth potential.
Negative Factors
Profit Margin Pressures
Margin pressures from tariffs can affect profitability, indicating potential challenges in maintaining cost efficiency.
Federal Segment Challenges
Challenges in the federal segment may limit growth opportunities and expose the company to regulatory and budgetary risks.
Cash Flow Challenges
Declining free cash flow indicates potential issues in cash generation, which could impact future investments and financial flexibility.

Axon Enterprise (AXON) vs. SPDR S&P 500 ETF (SPY)

Axon Enterprise Business Overview & Revenue Model

Company DescriptionAxon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
How the Company Makes MoneyAxon generates revenue primarily through the sale of its hardware products, such as body-worn cameras and related equipment, as well as subscription services for its digital evidence management platform, Evidence.com. The company employs a recurring revenue model, where law enforcement agencies pay for software subscriptions and service contracts, ensuring a steady cash flow. Additionally, Axon benefits from partnerships with various governmental and law enforcement organizations, providing tailored solutions that foster long-term relationships. The combination of hardware sales, subscription services, and strategic partnerships are key contributors to Axon's overall earnings.

Axon Enterprise Key Performance Indicators (KPIs)

Any
Any
Annual Recurring Revenue
Annual Recurring Revenue
Measures the predictable revenue generated from subscriptions or contracts, highlighting the stability and growth potential of the company's income stream.
Chart InsightsAxon's Annual Recurring Revenue has shown a robust upward trajectory, surpassing $1 billion in 2024 and continuing strong growth into 2025. The latest earnings call underscores this trend, highlighting a 33% year-over-year revenue increase and significant gains in software and services. The company's strategic focus on AI, drones, and international expansion is driving this momentum. However, potential tariff impacts and challenges in the Platform Solutions segment could pose risks to margins. Overall, Axon's commitment to innovation and strategic investments positions it well for sustained growth.
Data provided by:The Fly

Axon Enterprise Earnings Call Summary

Earnings Call Date:Nov 04, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 03, 2026
Earnings Call Sentiment Positive
The earnings call reflects a strong growth trajectory for Axon, with significant revenue increases, successful expansion in international markets, and promising new product launches. However, the impact of tariffs on margins and challenges in the federal segment are noted concerns. The company is optimistic about future growth, driven by innovative product developments and strategic acquisitions.
Q3-2025 Updates
Positive Updates
Strong Revenue Growth
Third quarter revenue of $711 million increased 31% year-over-year, marking the seventh consecutive quarter of 30% or greater growth.
Software and Services Leadership
Software and services revenue increased 41% year-over-year to $305 million, with strong net revenue retention at 124%.
Expanding International Presence
International markets delivered two of the top 10 deals, including a nine-figure cloud deal in Europe, indicating strong international growth potential.
Innovative Product Launches
Introduction of new products like ABW Mini and the integration of Prepared and Carbyne into the Axon ecosystem, aiming to enhance AI-enabled communications and public safety.
Positive Bookings Momentum
Year-to-date bookings are up over 30% and accelerating from last year, with a strong pipeline for Q4.
Negative Updates
Tariff Impact on Margins
Adjusted gross margin of 62.7% decreased 50 basis points year-over-year due to tariffs, impacting the Connected Devices segment.
Federal Segment Challenges
Federal contracts have not been a major contributor to growth this year, and there are uncertainties due to potential government shutdowns.
Company Guidance
During Axon's Third Quarter 2025 earnings call, the executive team highlighted several key metrics reflecting strong performance and future guidance. The company reported a 31% year-over-year increase in third quarter revenue, reaching $711 million, marking the seventh consecutive quarter of 30% or greater growth. Software and services revenue grew by 41% year-over-year to $305 million, while Connected Devices revenue grew by 24% to $405 million. Adjusted gross margin was reported at 62.7%, with an adjusted EBITDA margin of 24.9%. Looking ahead, Axon raised its revenue guidance for Q4 to between $750 million and $755 million, implying full-year revenue of about $2.74 billion, representing approximately 31% growth at the midpoint. The company also maintains its full-year target of a 25% adjusted EBITDA margin. Axon's strategic investments, including acquisitions of Prepared and Carbyne, are expected to advance their long-term vision and deliver significant value, particularly in the AI and voice communications sectors.

Axon Enterprise Financial Statement Overview

Summary
Axon Enterprise demonstrates strong revenue growth and a solid gross profit margin, reflecting effective cost management. However, profitability metrics such as net profit margin and EBIT margin have shown some decline, indicating potential operational inefficiencies. The balance sheet is stable with moderate leverage, but cash flow metrics suggest challenges in cash generation.
Income Statement
Axon Enterprise shows a strong revenue growth trajectory with a 7.38% increase in TTM. The gross profit margin is robust at 60.47%, indicating efficient cost management. However, the net profit margin has decreased to 13.64% from 18.10% in the previous year, and the EBIT margin is negative, reflecting potential operational challenges.
Balance Sheet
The company maintains a moderate debt-to-equity ratio of 0.75, suggesting a balanced approach to leverage. Return on equity is healthy at 13.43%, though it has decreased from the previous year. The equity ratio stands at 43.96%, indicating a strong equity base relative to total assets.
Cash Flow
Operating cash flow is positive, but the free cash flow has declined significantly by 51.33% in the TTM. The operating cash flow to net income ratio is 0.21, indicating that cash generation is lower relative to net income. The free cash flow to net income ratio is 0.64, showing some cash flow challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.56B2.08B1.56B1.19B863.38M681.00M
Gross Profit1.54B1.24B955.45M728.64M531.09M416.33M
EBITDA310.92M437.03M183.37M227.62M-117.11M6.28M
Net Income257.10M377.03M175.78M147.14M-60.02M-1.72M
Balance Sheet
Total Assets6.66B4.47B3.41B2.85B1.69B1.38B
Cash, Cash Equivalents and Short-Term Investments2.38B986.35M1.32B974.69M443.02M561.97M
Total Debt2.10B1.40B710.66M711.11M20.44M0.00
Total Liabilities3.63B2.15B1.79B1.58B640.36M404.77M
Stockholders Equity3.03B2.33B1.61B1.27B1.05B976.25M
Cash Flow
Free Cash Flow145.02M329.53M128.99M179.25M74.22M-34.39M
Operating Cash Flow244.27M408.31M189.26M235.36M124.49M38.48M
Investing Cash Flow-940.23M-490.57M12.48M-830.97M252.56M-356.53M
Financing Cash Flow1.44B-45.44M41.31M598.10M-174.18M299.26M

Axon Enterprise Technical Analysis

Technical Analysis Sentiment
Positive
Last Price612.98
Price Trends
50DMA
586.11
Positive
100DMA
659.66
Negative
200DMA
681.13
Negative
Market Momentum
MACD
8.20
Negative
RSI
59.70
Neutral
STOCH
80.79
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AXON, the sentiment is Positive. The current price of 612.98 is above the 20-day moving average (MA) of 581.50, above the 50-day MA of 586.11, and below the 200-day MA of 681.13, indicating a neutral trend. The MACD of 8.20 indicates Negative momentum. The RSI at 59.70 is Neutral, neither overbought nor oversold. The STOCH value of 80.79 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AXON.

Axon Enterprise Risk Analysis

Axon Enterprise disclosed 56 risk factors in its most recent earnings report. Axon Enterprise reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Axon Enterprise Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$82.35B21.2126.15%1.55%-0.14%72.35%
74
Outperform
$57.94B34.989.13%1.61%2.83%47.00%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
63
Neutral
$15.44B847.231.20%14.00%23.78%
58
Neutral
$49.00B194.0410.03%31.77%-15.34%
49
Neutral
$111.62M-10.58-14.61%-1.83%-642.89%
42
Neutral
$4.97M>-0.01-233.66%-9.62%95.79%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AXON
Axon Enterprise
612.98
42.98
7.54%
DGLY
Digital Ally
2.84
-2,577.16
-99.89%
LHX
L3Harris Technologies
325.74
120.52
58.73%
KTOS
Kratos Defense
104.04
74.67
254.24%
NOC
Northrop Grumman
590.79
139.93
31.04%
SSTI
SoundThinking Inc
8.96
-3.59
-28.61%

Axon Enterprise Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Axon Enterprise Announces Redemption of 2027 Convertible Notes
Neutral
Dec 18, 2025

On December 18, 2025, Axon Enterprise, Inc. announced that it had delivered a notice of redemption for its 0.50% convertible senior notes due 2027, electing to redeem all outstanding notes on February 10, 2026 at 100% of principal plus accrued and unpaid interest. Holders may convert their notes until the close of business on February 6, 2026, after which conversion will no longer be permitted, with Axon set to settle valid conversions through a mix of cash (for principal and any fractional share amounts) and shares of common stock for any value above principal, based on a 30-trading-day observation period running from December 24, 2025 through February 6, 2026; the move effectively accelerates the wind-down of this debt instrument and could influence Axon’s capital structure and shareholder dilution depending on the level of note conversions.

The most recent analyst rating on (AXON) stock is a Buy with a $713.00 price target. To see the full list of analyst forecasts on Axon Enterprise stock, see the AXON Stock Forecast page.

Private Placements and Financing
Axon Enterprise Announces Convertible Notes Exchange
Neutral
Dec 10, 2025

On December 9, 2025, Axon Enterprise, Inc. entered into agreements with certain holders of its 0.50% convertible senior notes due 2027 to exchange approximately $177.9 million of these notes for cash and common stock. This exchange is expected to close around December 16, 2025, and may influence the market price of Axon’s stock as hedged holders adjust their positions. The company will have about $100.1 million of notes outstanding post-exchange.

The most recent analyst rating on (AXON) stock is a Buy with a $925.00 price target. To see the full list of analyst forecasts on Axon Enterprise stock, see the AXON Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 19, 2025